Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

BCAC

Brookline Capital Acquis... (BCAC)

Brookline Capital Acquisition Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BCAC
DateHeureSourceTitreSymboleSociété
24/06/202300h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCACBrookline Capital Acquisition Corporation
25/05/202314h15Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BCACBrookline Capital Acquisition Corporation
24/05/202313h03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BCACBrookline Capital Acquisition Corporation
15/05/202322h56Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BCACBrookline Capital Acquisition Corporation
10/04/202322h04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:BCACBrookline Capital Acquisition Corporation
10/04/202312h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BCACBrookline Capital Acquisition Corporation
04/04/202322h26Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:BCACBrookline Capital Acquisition Corporation
22/02/202322h23Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:BCACBrookline Capital Acquisition Corporation
22/02/202322h11Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BCACBrookline Capital Acquisition Corporation
14/02/202312h15Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:BCACBrookline Capital Acquisition Corporation
13/02/202322h05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BCACBrookline Capital Acquisition Corporation
07/10/202212h03Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BCACBrookline Capital Acquisition Corporation
18/08/202222h49Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:BCACBrookline Capital Acquisition Corporation
08/08/202223h23Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BCACBrookline Capital Acquisition Corporation
01/08/202221h48Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BCACBrookline Capital Acquisition Corporation
27/06/202222h12Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:BCACBrookline Capital Acquisition Corporation
16/05/202222h58Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:BCACBrookline Capital Acquisition Corporation
11/04/202212h02Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:BCACBrookline Capital Acquisition Corporation
18/03/202222h22Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BCACBrookline Capital Acquisition Corporation
15/05/201913h30GlobeNewswire Inc.BISON CAPITAL ACQUISITION CORP. ANNOUNCES CLOSING OF ITS BUSINESS COMBINATION WITH XYNOMIC PHARMACEUTICALS, INC.NASDAQ:BCACBrookline Capital Acquisition Corporation
03/05/201922h45GlobeNewswire Inc.Bison Capital Acquisition Corp. Announces the Postponement of the Meeting Date for the Special Meeting of Shareholders to App...NASDAQ:BCACBrookline Capital Acquisition Corporation
29/04/201921h34GlobeNewswire Inc.Bison Capital Acquisition Corp. Announces Record and Meeting Dates for the Special Meeting of Shareholders to Approve Busines...NASDAQ:BCACBrookline Capital Acquisition Corporation
20/03/201918h45PR Newswire (US)Xynomic Pharmaceuticals, Inc. Will Present at ASCO 2019 Annual Meeting, Will Sponsor an EU Investigator Meeting for Potential...NASDAQ:BCACBrookline Capital Acquisition Corporation
16/03/201908h04PR Newswire (US)Xynomic Pharma Achieves Important Regulatory Milestones in China and EU in Potentially Pivotal Kidney Cancer and Lymphoma Tri...NASDAQ:BCACBrookline Capital Acquisition Corporation
23/02/201914h37PR Newswire (US)Xynomic Pharma Doses First South Korean Patient in Phase 3 Renal Cell Carcinoma Trial and Hires Senior Executive Dr. Sophia P...NASDAQ:BCACBrookline Capital Acquisition Corporation
18/10/201823h28GlobeNewswire Inc.Bison Capital Acquisition Corp. Clarifies Information of Its Chairman and PresidentNASDAQ:BCACBrookline Capital Acquisition Corporation
20/06/201704h48GlobeNewswire Inc.Bison Capital Acquisition Corp. Announces Pricing of $52.5 Million Initial Public OfferingNASDAQ:BCACBrookline Capital Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:BCAC

Dernières Valeurs Consultées

Delayed Upgrade Clock